Cargando…
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells
Human papillomaviruses (HPV) cause malignant epithelial cancers including cervical carcinoma, non-melanoma skin and head and neck cancer. They drive tumor development through the expression of their oncoproteins E6 and E7. Designer nucleases were shown to be efficient to specifically destroy HPV16 a...
Autores principales: | Ehrke-Schulz, Eric, Heinemann, Sonja, Schulte, Lukas, Schiwon, Maren, Ehrhardt, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409089/ https://www.ncbi.nlm.nih.gov/pubmed/32708897 http://dx.doi.org/10.3390/cancers12071934 |
Ejemplares similares
-
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Ehrke-Schulz, Eric, et al.
Publicado: (2017) -
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018) -
Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B
por: Gao, Jian, et al.
Publicado: (2018) -
A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions
por: Tsoukas, Raphael L., et al.
Publicado: (2022) -
A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration
por: Boehme, Philip, et al.
Publicado: (2016)